Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 14, 2004
Issued Date -
N/A
app pub date -
Jan 21, 2003
filing date -
Nov 10, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to compositions and methods for reversing advanced glycosylation end product-mediated cross-linking and protein aging. Accordingly, compositions are described which comprise thiazolium compounds substituted with heterocyclic groups which are capable of reversing the formation of advanced glycosylation end product cross-links. Both industrial and therapeutic applications for the invention are disclosed, as food spoilage and animal protein aging can be treated. Such compounds have particular application in the treatment of protein aging such as is responsible for the complications of aging and diabetes.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully